ResMed Inc. logo

ResMed Inc. (RMD)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
256. 55
+5.04
+2%
After Hours
$
263. 50
+6.95 +2.71%
37.49B Market Cap
27.49 P/E Ratio
1.92% Div Yield
578,001 Volume
6.52 Eps
$ 251.51
Previous Close
Day Range
254.4 257.98
Year Range
199.92 293.81
Want to track RMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 48 days
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Shares of ResMed (RMD) and Inspire Medical Systems (INSP) fell Monday as the companies behind products to treat sleep apnea faced a new threat from weight-loss drugs.

Investopedia | 11 months ago
3 Reasons Growth Investors Will Love ResMed (RMD)

3 Reasons Growth Investors Will Love ResMed (RMD)

ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 11 months ago
Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 11 months ago
Why ResMed (RMD) is a Top Value Stock for the Long-Term

Why ResMed (RMD) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 11 months ago
RMD or PODD: Which Is the Better Value Stock Right Now?

RMD or PODD: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with ResMed (RMD) and Insulet (PODD). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 11 months ago
Here is Why Growth Investors Should Buy ResMed (RMD) Now

Here is Why Growth Investors Should Buy ResMed (RMD) Now

ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 0 year ago
Here's Why ResMed (RMD) is a Strong Momentum Stock

Here's Why ResMed (RMD) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
RMD vs. LMAT: Which Stock Is the Better Value Option?

RMD vs. LMAT: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Products sector might want to consider either ResMed (RMD) or LeMaitre Vascular (LMAT). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Zacks | 1 year ago
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago
Here's Why You Should Add RMD Stock to Your Portfolio Now

Here's Why You Should Add RMD Stock to Your Portfolio Now

Robust Mask and Device sales bode well for ResMed. Meanwhile, the increasing debt burden adds to the worry.

Zacks | 1 year ago
Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"

ResMed (RMD) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 1 year ago
Loading...
Load More